Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
07/2011
07/20/2011EP1377578B1 Beta-carboline derivatives and its pharmaceutical use against depression and anxiety
07/20/2011CN102131810A Diketone fused azolopiperidines and azolopiperazines as anti-hiv agents
07/20/2011CN102131807A Pyrazolopyridine kinase inhibitors
07/20/2011CN102127096A Triazole pyridine and triazole pyrazine compound and composition and application thereof
07/13/2011EP2343290A1 Diamine derivatives as factor X inhibitors
07/13/2011EP2342335A1 Novel gene cluster
07/13/2011EP2342202A1 Azaindole derivative
07/13/2011EP1463502B1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
07/13/2011CN1353609B Amide substituted imidazoquinolines
07/13/2011CN102124011A Inhibitors of human immunodeficiency virus replication
07/13/2011CN102124005A Cmet inhibitors
07/13/2011CN101166742B Novel lactam compound
07/12/2011US7977353 Heterocyclic aromatic compounds useful as growth hormone secretagogues
07/07/2011WO2010111406A3 Purine derivatives useful as anti - cancer agents
07/07/2011US20110166167 Bicyclic heterocycle derivatives and methods of use thereof
07/06/2011EP2341053A1 Cephalosporin having catechol group
07/06/2011EP2340244A1 Compounds and methods of use
07/06/2011CN102115478A Furo-indole compounds and preparation method and application thereof
07/06/2011CN101648962B C3/C3 fluoroquinolone dipolymer derivative taking s-triazolo-[3,4-b][1,3,4] thiadiazole as connecting chain and preparation method and application thereof
07/05/2011US7973031 Leukemia therapy ;myelodyspastic syndrome
06/2011
06/30/2011WO2011079076A1 Substituted n-(1h-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cfms inhibitors
06/30/2011WO2011078795A1 Bridged morpholino substituted purines
06/29/2011EP2338925A1 -electron conjugated compound, manufacturing method therefor, and -electron conjugated polymer obtained using same
06/28/2011US7968556 Heteroaryl compounds, compositions thereof, and methods of treatment therewith
06/28/2011CA2467672C Chemokine receptor antagonists and methods of use therefor
06/28/2011CA2445834C Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
06/23/2011WO2011075643A1 Substituted heteroaryl fused derivatives as pi3k inhibitors
06/23/2011WO2011075628A1 Heterocyclic compounds and their uses
06/23/2011WO2011073231A1 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4, 3-c] ISOQUINOLINE DERIVATIVES
06/23/2011WO2011072779A1 Thiazole derivatives for treating diseases such as cancer
06/23/2011US20110152296 Heterocyclic compounds and their uses
06/23/2011US20110152280 Novel ergoline analogs
06/23/2011US20110152242 2,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 Antagonists
06/23/2011CA2784566A1 Heterocyclic compounds and their uses
06/23/2011CA2784067A1 Thiazole derivatives for the treatment of diseases such as cancer
06/23/2011CA2784013A1 3,4,4a,10b-tetrahydro-1h-thiopyrano-[4, 3-c] isoquinoline derivatives
06/22/2011EP2335702A1 Product containing at least one phosphatase Cdc25 inhibitor combined with at least one other anticancer agent
06/22/2011EP2334689A2 Fused heterocyclic compound
06/22/2011EP2334688A1 Active materials for photoelectric devices
06/22/2011CN102101868A 1,1'-bicarboline N,N'-dioxocompound and synthesis and application thereof
06/22/2011CN102101859A Quinolone carboxylic acid derivatives and application thereof
06/22/2011CN101035796B Method of producing a composition, composition and its use
06/21/2011CA2676892C Ketal amide compounds, methods of making, and applications
06/21/2011CA2483562C Heterotricyclyl-6-alkylidene-penems as beta-lactamase inhibitors
06/16/2011WO2011070963A1 Organic light-emitting material and organic light-emitting element
06/16/2011WO2011021726A3 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
06/16/2011US20110144177 Carbamoyl Esters That Inhibit Cholinesterase And Release Pharmacologically Active Agents
06/16/2011US20110140092 Charge transport compositions and electronic devices made with such compositions
06/15/2011EP2332940A1 Azaindoles useful as inhibitors of JAK and other protein kinases
06/15/2011EP1838718B1 Pyrrolopyrazoles, potent kinase inhibitors
06/15/2011CN1930145B Cycloalkanopyridine derivative
06/15/2011CN102093395A Synthesis method of spiro orthoester monomer
06/15/2011CN101817825B Bi-dihydroxy ethylene urea, derivatives, preparation method and application thereof
06/14/2011US7960411 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
06/09/2011WO2011006143A3 Fused imidazoles and compositions comprising them for the treatment of parasitic diseases, such as e.g. malaria
06/09/2011US20110133173 Charge transport compositions and electronic devices made with such compositions
06/09/2011CA2781891A1 Novel tricyclic compounds
06/09/2011CA2781010A1 Novel tricyclic compounds
06/08/2011EP2328890A1 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors
06/08/2011CN102089313A 9-substituted-b-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
06/08/2011CN102086211A Aromatic heterocyclic compounds serving as protein kinase inhibitor
06/08/2011CN101510590B Organic electroluminescent element and display
06/03/2011CA2782024A1 Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
06/02/2011US20110130364 Pyrrolopyridine derivatives substituted with cyclic amino group
06/01/2011EP2326652A1 Nitro derivatives of furasemide and their use as diuretics
06/01/2011EP2326647A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazoioý4,5- c¨pyridinyl)purine and purinone derivatives for immunosuppression
06/01/2011CN1615335B Preparation method of synergistic stabilizer mixture
05/2011
05/31/2011US7951949 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of Alzheimer's disease
05/31/2011US7951811 Pyrrolo[2,3-D]pyrimidine derivatives substituted with a cyclic amino group
05/31/2011CA2501365C Inhibitors of akt activity
05/31/2011CA2319080C Multivalent antibacterial agents
05/26/2011WO2011061157A1 Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof
05/26/2011WO2011060867A1 Nitrogen-containing condensed heterocyclic compounds for oleds
05/26/2011WO2011028829A3 Organic electronic devices and polymers, including photovoltaic cells and diketone-based and diketopyrrolopyrrole-based polymers
05/26/2011US20110124862 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
05/26/2011US20110124629 Crystalline Forms of a Pharmaceutical Compound
05/26/2011CA2780977A1 Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof
05/25/2011EP2325186A2 Fused Bicyclic mTor Inhibitors
05/25/2011EP2324036A1 Bicyclic heterocycle derivatives and methods of use thereof
05/25/2011EP2324035A1 Substituted n-phenyl-2,3-dihydroimidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligands
05/25/2011EP2324029A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease
05/25/2011EP2035436B1 Fused thiazole derivatives as kinase inhibitors
05/25/2011CN102076693A Substituted tricyclic derivatives against neurodegenerative diseases
05/25/2011CN102076686A Diketopiperidine derivatives as HIV attachment inhibitors
05/25/2011CN102070771A Perylene diimide photoelectric functional materials and preparation method thereof
05/25/2011CN101171257B Pyrrolobenzodiazepines compound
05/24/2011CA2497569C 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound
05/24/2011CA2384378C Heterocyclic compounds useful as inhibitors of tyrosine kinases
05/19/2011WO2011059839A1 Bicyclic pyridines and analogs as sirtuin modulators
05/19/2011WO2011058025A1 N-7 substituted purine and pyrazolopyrimidine compounds, compositions and methods of use
05/19/2011CA2780812A1 Hepatitis c virus inhibitors
05/19/2011CA2780018A1 N-7 substituted purine and pyrazolopyrimidine compounds, compositions and methods of use
05/19/2011CA2779303A1 Bicyclic pyridines and analogs as sirtuin modulators
05/18/2011EP2322524A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
05/17/2011US7943624 Pyridinylpyrazolopyrimidinone derivatives as PDE 7 inhibitors
05/17/2011US7943616 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders
05/12/2011WO2011056573A1 Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
05/12/2011WO2011056503A1 Azabicyclo[2.2.1] heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands
05/12/2011WO2011054190A1 Melonine bisindole compounds, pharmaceutical compositions, preparation method and use thereof
05/12/2011WO2011027081A3 Derivatives of 5,6,7,8-tetrahydroindolizine inhibiting hsp90, compositions containing same, and use thereof
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 111